Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 7
Submit an article Journal homepage
419
Views
8
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Cell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma

Anne O. GangDepartment of Hematology
,
Mette Ø. PedersenDepartment of Pathology, Herlev Hospital, Herlev, Denmark
,
Helle KnudsenDepartment of Pathology, Herlev Hospital, Herlev, Denmark
,
Anne F. LauritzenDepartment of Pathology, Herlev Hospital, Herlev, Denmark
,
Michael PedersenDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark
,
Signe L. NielsenDepartment of Pathology, Herlev Hospital, Herlev, Denmark
,
Peter BrownDepartment of Hematology, Rigshospitalet, Copenhagen, Denmark
,
Estrid HøgdallDepartment of Pathology, Herlev Hospital, Herlev, Denmark
,
Tobias W. KlausenDepartment of Hematology
&
Peter NørgaardDepartment of Pathology, Herlev Hospital, Herlev, DenmarkCorrespondence[email protected]
 show all
Pages 2039-2046 | Received 04 Sep 2014, Accepted 27 Oct 2014, Published online: 21 Jan 2015

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Armin Rashidi, Eunhye Oak, Kenneth R. Carson, Nina D. Wagner-Johnston, Friederike Kreisel & Nancy L. Bartlett. (2016) Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria. Leukemia & Lymphoma 57:5, pages 1191-1193.
Read now
N. George Mikhaeel. (2015) Is 70 the new 60? New international prognostic index with an older age cut-off for diffuse large B-cell lymphoma. Leukemia & Lymphoma 56:9, pages 2487-2488.
Read now

Articles from other publishers (6)

Maike Stegemann, Sophy Denker & Clemens A. Schmitt. (2022) DLBCL 1L—What to Expect beyond R-CHOP?. Cancers 14:6, pages 1453.
Crossref
Vicki A. Morrison. (2021) Frontline therapy with R-CHOP for diffuse large B-cell lymphoma: Where have we come (or not come)? A Perspective. Journal of Geriatric Oncology 12:2, pages 320-325.
Crossref
Rakesh Kumar MauryaT. E. C. Cummin, M. S. Cragg, J. W. Friedberg & P. W. M. Johnson. 2019. Reciprocating Engine Combustion Diagnostics. Reciprocating Engine Combustion Diagnostics 343 360 .
Lamia Abdalkader, Takashi Oka, Katsuyoshi Takata, Hiaki Sato, Ichiro Murakami, Arie P. Otte & Tadashi Yoshino. (2016) Aberrant differential expression of EZH1 and EZH2 in Polycomb repressive complex 2 among B- and T/NK-cell neoplasms. Pathology 48:5, pages 467-482.
Crossref
Amir Behdad & Nathanael G. Bailey. (2016) Comprehensive Assessment and Classification of High-Grade B-cell Lymphomas. Surgical Pathology Clinics 9:1, pages 41-54.
Crossref
Fritz OffnerOlga SamoilovaEvgenii OsmanovHyeon-Seok EomMax S. ToppJoão RaposoViacheslav PavlovDeborah RicciShalini ChaturvediEugene ZhuHelgi van de Velde, Christopher EnnyAleksandra RizoBurhan Ferhanoglu. (2015) Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL. Blood 126:16, pages 1893-1901.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.